This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

S. Jordan Kerns, PhD
Director of Applied Biosciences at Emulate, Inc., USA


S. Jordan Kerns is the Director of the Applied BioSciences Team at Emulate, Inc., where he leads a team responsible for the design and execution of studies performed on Emulate’s flagship Organ-Chip models targeted to applications throughout the pharmaceutical drug development pipeline. At Emulate, Jordan pioneered many new capabilities to model resident and peripheral immunity in Organ-Chips for applications in disease modeling and investigative toxicology. He has played key leadership and technical roles in several of Emulate’s large industry partnerships by formulating the scientific strategy and applying broad scientific expertise, innovative approaches, and advanced methodologies. Jordan brings this strategic and innovative mindset the Applied BioSciences Team to help pharmaceutical partners make better predictions and decisions on their lead programs.

Prior to joining Emulate, Jordan worked with Donald Ingber at the Wyss Institute for Biologically Inspired Engineering at Harvard University where he spearheaded the development of novel bacterial biosensors for diagnostic applications using the Intestine-Chip platform. Based on this work he received multiple awards including a Gates Grand Challenge Exploration Award from the Bill and Melinda Gates Foundation and was instrumental in securing a multi-million dollar DARPA grant. Jordan is a broadly talented scientist with expertise in biophysics, synthetic biology, and developing models of gastrointestinal diseases and host-microbial interactions. Jordan received his PhD in Biophysics and Structural Biology from Brandeis University and has been primary author on several research articles and numerous patents.

Agenda Sessions

  • Human Liver-Chips: Qualifying a Preclinical Model System for AAV Vector Development